InteRNA Technologies BV:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:InteRNA Technologies BV - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C2794
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オランダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
InteRNA Technologies BV (InteRNA) is a biotechnology company that develops RNA therapeutics for the treatment of cancer. The company develops technologies in biomedical research translating miRNA sequence fields. Its drug development programs offers developing miRNA-based therapeutics that controls genes connected in signal transduction pathways. InteRNA’s technologies comprise deep sequencing and bioinformatics, miRNA expression database, data analyses platform and lentiviral-based miRNA overexpression library, among others. The company specializes in oncology programs including in vivo proof of concept for non-formulated anti-miRNA mimics, demonstrating significant tumor suppression in a mouse tumor xenograft model and development of a miRNA compound for mutant B-Raf associated solid tumors. InteRNA is headquartered in Nijmegen, the Netherlands.

InteRNA Technologies BV – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
InteRNA Technologies BV, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
InteRNA Technologies BV, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
InteRNA Technologies BV, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
InteRNA Technologies BV, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
InteRNA Technologies BV, Medical Devices Deals, 2012 to YTD 2018 9
InteRNA Technologies BV, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
InteRNA Technologies BV, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
InteRNA Technologies Raises Additional Funds in Series A Financing 11
InteRNA Technologies Raises Funds Through Venture Financing 12
Partnerships 13
InteRNA Technologies Enters into Agreement with Fraunhofer-Gesellschaft zur Forderung der Angewandten Forschung 13
InteRNA Technologies BV – Key Competitors 14
InteRNA Technologies BV – Key Employees 15
InteRNA Technologies BV – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
InteRNA Technologies BV, Pharmaceuticals & Healthcare, Key Facts 2
InteRNA Technologies BV, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
InteRNA Technologies BV, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
InteRNA Technologies BV, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
InteRNA Technologies BV, Deals By Therapy Area, 2012 to YTD 2018 8
InteRNA Technologies BV, Medical Devices Deals, 2012 to YTD 2018 9
InteRNA Technologies BV, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
InteRNA Technologies Raises Additional Funds in Series A Financing 11
InteRNA Technologies Raises Funds Through Venture Financing 12
InteRNA Technologies Enters into Agreement with Fraunhofer-Gesellschaft zur Forderung der Angewandten Forschung 13
InteRNA Technologies BV, Key Competitors 14
InteRNA Technologies BV, Key Employees 15
InteRNA Technologies BV, Other Locations 16

List of Figures
InteRNA Technologies BV, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
InteRNA Technologies BV, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
InteRNA Technologies BV, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
InteRNA Technologies BV, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
InteRNA Technologies BV, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
InteRNA Technologies BV, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
InteRNA Technologies BV, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
InteRNA Technologies BV, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
InteRNA Technologies BV, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[InteRNA Technologies BV:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Eindec Corporation Ltd (42Z):企業の財務・戦略的SWOT分析
    Eindec Corporation Ltd (42Z) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Hayashibara Co Ltd:企業の戦略的SWOT分析
    Hayashibara Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Unipetrol, a.s. (UNIPE):石油・ガス:M&Aディール及び事業提携情報
    Summary Unipetrol AS (Unipetrol), a subsidiary of Polski Koncern Naftowy Orlen SA, is refinery and petrochemical company. The company produces and sells petroleum products, petrochemicals, plastics and specialty chemicals. Unipetrol owns and operates transport services, filling stations and carries …
  • PTT Exploration and Production Public Company Limited:企業の戦略・SWOT・財務分析
    PTT Exploration and Production Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary PTT Exploration and Production Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's …
  • Fuerst Day Lawson Ltd:企業の戦略・SWOT・財務情報
    Fuerst Day Lawson Ltd - Strategy, SWOT and Corporate Finance Report Summary Fuerst Day Lawson Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Cisco Systems Inc (CSCO):電力:M&Aディール及び事業提携情報
    Summary Cisco Systems Inc (Cisco) designs, manufactures and sells Internet protocol (IP)-based networking systems and other products. The company’s products are blade switches, analytics and automation software, application networking services, interfaces and modules, optical networking, security, s …
  • Bm-Bank Public Joint Stock Company:企業の戦略・SWOT・財務分析
    Bm-Bank Public Joint Stock Company - Strategy, SWOT and Corporate Finance Report Summary Bm-Bank Public Joint Stock Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Siccar Point Energy Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Siccar Point Energy Ltd (Siccar Point) is an oil and gas company that offers exploration and development of energy fields. The company acquires, and targets both operated and non-operated opportunities. Its exploration areas include Schiehallion field, Rosebank field, Suilven field, Cambo fi …
  • Veolia Environnement SA (VIE):電力:M&Aディール及び事業提携情報
    Summary Veolia Environnement SA (Veolia) is an environmental management services company that designs and offers water, waste and energy management solutions. Its service offerings include wastewater and sanitation services, drinking water treatment and distribution and waste management and energy s …
  • Enercon Services Inc:企業の戦略的SWOT分析
    Enercon Services Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Banco Bilbao Vizcaya Argentaria SA:戦略・SWOT・企業財務分析
    Banco Bilbao Vizcaya Argentaria SA - Strategy, SWOT and Corporate Finance Report Summary Banco Bilbao Vizcaya Argentaria SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Sensient Technologies Corp (SXT):企業の財務・戦略的SWOT分析
    Sensient Technologies Corp (SXT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Diamyd Medical AB (DMYD B):製薬・医療:M&Aディール及び事業提携情報
    Summary Diamyd Medical AB (Diamyd), formerly Diamyd Therapeutics AB is a drug development company that offers diabetes vaccine. The company's diabetes products include Diamyd, an antigen-based immunotherapy for the treatment of autoimmune diabetes. Its pipeline products include GAD, GABA, and other …
  • NuVasive Inc (NUVA):製品パイプライン分析
    Summary NuVasive Inc (NuVasive) is a medical device company that provides minimally invasive, procedurally-integrated spine solutions. The company principally provides Maximum Access Surgery (MAS), a minimally-disruptive surgical platform. MAS platform enables surgeons to perform a range of minimall …
  • Swissport International Ltd.:企業の戦略・SWOT・財務情報
    Swissport International Ltd. - Strategy, SWOT and Corporate Finance Report Summary Swissport International Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Tp Icap Plc
    Tp Icap Plc - Strategy, SWOT and Corporate Finance Report Summary Tp Icap Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • MitoGenetics LLC-製薬・医療分野:企業M&A・提携分析
    Summary MitoGenetics LLC (MitoGenetics) is a biomedical research and development company which produces proprietary compounds and intellectual property for the treatment of human, animal and plant diseases caused due to mitochondrial dysfunction. The company offers technology to regulate cellular mi …
  • Circassia Pharmaceuticals Plc (CIR):製薬・医療:M&Aディール及び事業提携情報
    Summary Circassia Pharmaceuticals plc (Circassia) develops and manufactures drugs for the treatment of allergy and respiratory diseases such as asthma. The company’s marketed products include Niox used to assist asthma management and Tudorza for the treatment of chronic obstructive pulmonary disease …
  • Juntendo University:製薬・医療:M&Aディール及び事業提携情報
    Summary Juntendo University (Juntendo) is a healthcare service provider that offers medical education and research programs and services. The university offers services such as medical education, practices and healthcare services including nursing, consultation, emergency room services, and others. …
  • The Bank of East Asia, Limited:企業の戦略・SWOT・財務情報
    The Bank of East Asia, Limited - Strategy, SWOT and Corporate Finance Report Summary The Bank of East Asia, Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆